FDA Announces Third-Party Review Program Under FDAMA and Terminates Pilot Program

Summary

The Food and Drug Administration (FDA) is launching a program to accredit third-party reviewers to assess premarket medical device notifications and classify them. The agency is also terminating its Third Party Review Pilot Program and requesting OMB approval for an emergency processing request.